Clinical Trial Detail

NCT ID NCT02527174
Title A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia (VIAC)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Alberta
Indications

bone marrow cancer

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + Volasertib

Age Groups: adult

No variant requirements are available.